"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 2 | 17 | 19 |
| 2005 | 6 | 38 | 44 |
| 2006 | 7 | 48 | 55 |
| 2007 | 5 | 46 | 51 |
| 2008 | 13 | 59 | 72 |
| 2009 | 11 | 58 | 69 |
| 2010 | 12 | 59 | 71 |
| 2011 | 7 | 80 | 87 |
| 2012 | 8 | 63 | 71 |
| 2013 | 15 | 88 | 103 |
| 2014 | 13 | 90 | 103 |
| 2015 | 12 | 90 | 102 |
| 2016 | 15 | 94 | 109 |
| 2017 | 13 | 94 | 107 |
| 2018 | 15 | 85 | 100 |
| 2019 | 15 | 66 | 81 |
| 2020 | 9 | 75 | 84 |
| 2021 | 6 | 59 | 65 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 27 | 27 |
| 2024 | 5 | 38 | 43 |
| 2025 | 3 | 43 | 46 |
| 2026 | 2 | 31 | 33 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma. Neuro Oncol. 2026 Oct 01; 28(10):2472-2484.
-
Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma. Neuro Oncol. 2026 Oct 01; 28(10):2485-2499.
-
A metabolic-epigenetic switch governs multicellular cardiac repair following succinate dehydrogenase inhibition. Nat Cardiovasc Res. 2026 Oct; 5(10):1034-1054.
-
CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target. J Exp Med. 2026 Oct 05; 223(10).
-
Dynamic fluid flow and endothelial cross talk regulate mesangial homeostasis in a simplified 3-D coculture model. Am J Physiol Renal Physiol. 2026 Sep 01; 331(3):F513-F528.
-
Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2026 Dec; 268(Pt 2):116079.
-
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. Blood. 2026 08 06; 148(6):751-766.
-
Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma. Mol Cancer Ther. 2026 Aug 04; 25(8):1342-1356.
-
Immunoglobulin Superfamily Protein BTNL9 Functions as a Non-Canonical Transcriptional Regulator to Suppress NSCLC Through Cell Cycle and p53 Pathways. Int J Mol Sci. 2026 Jul 24; 27(15).
-
Glioblastoma stem cell growth requires DOT1L-MED23 control of enhancer accessibility. Cell Rep. 2026 Jul 28; 45(7):117647.